Retatrutide 20mg
20mg
Retatrutide is a next-generation triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously — making it the most advanced metabolic research compound available. Studies have demonstrated superior weight reduction outcomes compared to dual-agonist peptides, with research subjects showing significant reductions in body fat, improved insulin sensitivity, and favourable changes in lipid profiles. This 20mg vial offers researchers a high-purity supply for extended study protocols. Third-party HPLC tested. Lyophilised powder, requires reconstitution with bacteriostatic water.
Crypto payments only — How to pay guide
Documentation
COA-backed
Source
Manufacturer COA
Shipping
Australia-wide
Payment
Crypto only
RetaLABS Retatrutide 20mg is a lyophilised research vial of LY3437943 — a triple GLP-1, GIP, and Glucagon receptor agonist. At the 4mg/week starting dose used in Phase 2 cohorts, a single 20mg vial supplies five weeks of research. At the 8mg/week maintenance dose, it covers approximately 2.5 weeks of protocol.
Supplied as a white lyophilised powder. Shipped via Express Post Australia-wide in discrete, unmarked packaging — typically dispatched within 1–2 business days of confirmed crypto payment (BTC, LTC, or XMR).
For reconstitution protocol and storage guidance see the Peptide Reconstitution Guide. For Phase 2 trial data and dosing schedules see the Retatrutide Dosing Protocol.
Product Specifications
COA-backed, manufacturer-verified
Lyophilised powder
~4.4 kDa
-20°C (lyophilised), 2-8°C (reconstituted)
Bacteriostatic water or sterile saline
Available upon request
Research Use Only: These products are intended for laboratory research use only and are not approved for human consumption. All purchases are subject to our terms of service and local regulations.
Frequently Asked Questions
Everything you need to know about Retatrutide 20mg
Research Guides
Retatrutide Australia 2026: Research Guide, Mechanism, Trial Data & Reconstitution
15 min read
Retatrutide 2026: Phase 3 Trials and What Researchers Should Know
6 min read
Retatrutide vs Tirzepatide: Triple vs Dual GLP-1 Agonism in Research
8 min read
Buying Research Peptides with Crypto in Australia: A Practical Guide
5 min read
Retatrutide Dosing Protocol: Phase 2 Trial Reference for Researchers
8 min read